HB 526 protects mothers' right to breastfeed their children in any public or private location where they are otherwise permitted to be, without being considered indecent exposure, a nuisance, or obscenity. It defines "breastfeeding" to include both direct feeding and expressing milk for bottle-feeding, and creates a private right to sue for violations, allowing recovery of $1,000 per incident plus attorney fees. The law applies broadly across Pennsylvania, ensuring mothers can feed their children without legal interference while maintaining existing protections from the repealed 2007 Freedom to Breastfeed Act.
HB 1945 amends Pennsylvania's Controlled Substance Act to expand legal immunity for individuals who call 911 during a drug overdose. It directly affects bystanders and overdose victims who seek emergency help, protecting them from drug possession charges when reporting an overdose. The bill strengthens existing immunity by broadening the circumstances under which calling for assistance won't lead to criminal penalties. This policy change aims to encourage prompt emergency response without fear of legal repercussions for drug-related offenses.
HR 253 is a resolution directing Pennsylvania's Joint State Government Commission to create a task force and advisory committee focused on improving access to drug and alcohol treatment for people with substance use disorders. The task force, composed of four legislative members appointed by leadership, will work with an advisory committee of 26 stakeholders - including health officials, treatment providers, law enforcement, recovery advocates, and individuals in recovery - to examine barriers to treatment, review existing policies, and gather input from families and communities. The committee will analyze prevention services, recovery support, and quality care factors, then submit recommendations to the legislature within one year. This resolution does not change current law but establishes a process to inform future policy decisions on substance use disorder treatment access.
Pennsylvania's SB 785 establishes new antitrust rules to promote fair competition, primarily affecting health care providers, insurers, and health systems. The bill creates a legal right for both businesses and consumers (including indirect purchasers like patients) to sue for antitrust violations and requires health care entities to notify the state before merging or acquiring other health care businesses. It prohibits monopolistic practices, mandates divestiture of assets if mergers harm competition, and imposes fines of at least $100,000 per violation. The law aims to prevent anti-competitive behavior in health care markets while allowing private lawsuits and state enforcement.
Senate Resolution 105 recognizes May 2025 as "National Treatment Court Month" in Pennsylvania. This resolution aims to raise awareness about the effectiveness of various treatment courts, such as Drug Courts and Mental Health Courts, in addressing underlying issues contributing to criminal behavior and promoting recovery.
HB 416 establishes a new Child Care Staff Recruitment and Retention Program to support early childhood educators and creates a Rural Health Transformation Program to improve healthcare access in underserved areas. It also streamlines permit processes for economic development projects through the Streamlining Permits for Economic Expansion and Development Program. These provisions are integrated into the 2025 state budget implementation, alongside administrative updates to tax collection procedures, state fund management, and reporting requirements for agencies like the Department of Revenue and Treasury. The bill does not alter existing tax rates or create new funding streams but modifies how current state financial systems operate.
HB 595 requires Pennsylvania's Medicaid program to integrate mental health, addiction, and physical health services into a single managed care system for all eligible residents. The bill mandates that the state contract with managed care organizations to provide comprehensive, community-based care addressing both behavioral and physical health needs, while also addressing social factors affecting health. It requires the state to seek federal waiver approval by October 1, 2025, to implement this integration, including mandatory enrollment for all Medicaid-eligible individuals in the new system. This change aims to improve care coordination and create a more efficient health care delivery model.
SB 516 establishes Pennsylvania's "Lifetime Recovery from Substance Use Grant Program" to fund recovery support services. It requires the Department of Health to create and distribute posters/pamphlets with overdose signs, emergency steps, and naloxone locations to be displayed in public areas of government agencies, transit authorities, and municipalities. The bill directly affects nonprofits, hospitals, counties, and recovery houses that provide services like peer support, housing assistance, and job training for people recovering from substance use. It mandates these providers to apply for grants to expand access to evidence-based recovery support services across the state.
HB 1974 creates a new Contingency Management Support Grant Program within the Department of Drug and Alcohol Programs. The bill establishes a mechanism for distributing grants to support substance use disorder treatment programs that use evidence-based contingency management approaches (like providing rewards for treatment adherence). This program directly affects licensed treatment providers and individuals receiving substance use disorder services by providing funding for these specific support services. The bill amends the 1929 Administrative Code to authorize this grant program under the department's existing authority.
SB 95 amends Pennsylvania's Pharmacy Act to create a 180-day provisional license for pharmacists moving from other states, allowing them to practice without demonstrating competency under Pennsylvania's requirements. It also permits emergency medical services providers to distribute naloxone dose packages for opioid overdose reversal under specific conditions, including a Department of Health standing order and voluntary distribution without liability. Additionally, the bill requires pharmacies to disclose prescription drug prices (brand vs. generic), cost-sharing amounts, and health insurance options upon customer request. These changes aim to improve pharmacist mobility, expand naloxone access, and increase price transparency for consumers.
